For: | Liengswangwong U, Karalak A, Morishita Y, Noguchi M, Khuhaprema T, Srivatanakul P, Miwa M. Immunohistochemical expression of mismatch repair genes: A screening tool for predicting mutator phenotype in liver fluke infection-associated intrahepatic cholangiocarcinoma. World J Gastroenterol 2006; 12(23): 3740-3745 [PMID: 16773692 DOI: 10.3748/wjg.v12.i23.3740] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i23/3740.htm |
Number | Citing Articles |
1 |
Boris R.A. Blechacz, Gregory J. Gores. Molecular Genetics of Liver Neoplasia. 2010; : 75 doi: 10.1007/978-1-4419-6082-5_5
|
2 |
J. Y. H. Chan, K. K. H. Lee, Y. L. Chui. Hilar Cholangiocarcinoma. 2013; : 111 doi: 10.1007/978-94-007-6473-6_10
|
3 |
Apurva Jain, Lawrence N Kwong, Milind Javle. Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice. Current Treatment Options in Oncology 2016; 17(11) doi: 10.1007/s11864-016-0432-2
|
4 |
Ayse Z. Sahan, Tapas K. Hazra, Soumita Das. The Pivotal Role of DNA Repair in Infection Mediated-Inflammation and Cancer. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00663
|
5 |
Elena Czink, Matthias Kloor, Benjamin Goeppert, Stefan Fröhling, Sebastian Uhrig, Tim F. Weber, Jörn Meinel, Christian Sutter, Karl Heinz Weiss, Peter Schirmacher, Magnus von Knebel Doeberitz, Dirk Jäger, Christoph Springfeld. Successful immune checkpoint blockade in a patient with advanced stage microsatellite-unstable biliary tract cancer. Molecular Case Studies 2017; 3(5): a001974 doi: 10.1101/mcs.a001974
|
6 |
THANAA E.A. HELAL, NAHED S. KHAMIS, TAREK M. EL‐SHARKAWY, OLA H. NADA, NEHAL A. RADWAN. Immunohistochemical expression of mismatch repair genes (hMSH2 and hMLH1) in hepatocellular carcinoma in Egypt. APMIS 2010; 118(12): 934 doi: 10.1111/j.1600-0463.2010.02658.x
|
7 |
Vishal S. Chandan. Surgical Pathology of Liver Tumors. 2015; : 435 doi: 10.1007/978-3-319-16089-4_15
|
8 |
Qi Zhou, Li Ji, Xueying Shi, Dawei Deng, Fangyue Guo, Zhengpeng Wang, Wenhui Liu, Jinnan Zhang, Shilin Xia, Dong Shang. INTS8 is a therapeutic target for intrahepatic cholangiocarcinoma via the integration of bioinformatics analysis and experimental validation. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-03017-0
|
9 |
Nora Katabi, Juan Carlos Roa, N. Volkan Adsay. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5: 881 doi: 10.1007/978-1-4419-7107-4_60
|
10 |
Natcha Khuntikeo, Sureerat Padthaisong, Watcharin Loilome, Poramate Klanrit, Soontaree Ratchatapusit, Anchalee Techasen, Apiwat Jareanrat, Vasin Thanasukarn, Tharatip Srisuk, Vor Luvira, Jarin Chindaprasirt, Prakasit Sa-ngiamwibool, Chaiwat Aphivatanasiri, Piyapharom Intarawichian, Supinda Koonmee, Piya Prajumwongs, Attapol Titapun. Mismatch Repair Deficiency Is a Prognostic Factor Predicting Good Survival of Opisthorchis viverrini-Associated Cholangiocarcinoma at Early Cancer Stage. Cancers 2023; 15(19): 4831 doi: 10.3390/cancers15194831
|
11 |
Tavan Janvilisri, Kawin Leelawat, Sittiruk Roytrakul, Atchara Paemanee, Rutaiwan Tohtong. Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/105358
|
12 |
Meng-Shin Shiao, Khajeelak Chiablaem, Varodom Charoensawan, Nuttapong Ngamphaiboon, Natini Jinawath. Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type. Frontiers in Genetics 2018; 9 doi: 10.3389/fgene.2018.00309
|